Dana HARB (2014) “The Off-Label Use of Rituximab for the Management of Inflammatory Disorders: American University of Beirut Medical Center Experience”, Archives of Rheumatology, 29(3), pp. 194–202. doi: 10.5606/ArchRheumatol.2014.3855.